This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, J.-Y. Articles by Choi, H.-S. Search for Related Content PubMed PubMed Citation Articles by Kim, J.-Y. Articles by Choi, H.-S.

Orphan Nuclear Receptor Small Heterodimer Partner Represses Hepatocyte Nuclear Factor 3/Foxa Transactivation via Inhibition of Its DNA Binding

Hormone Research Center (J.-Y.K., H.-J.K., Y.-Y.P., H.-S.C.), School of Biological Sciences and Technology, Chonnam National University, Gwangju 500-757; Department of Biochemistry and Molecular Biology (K.T.K., S.C.P.), The Aging and Apoptosis Research Center, Seoul National University College of Medicine, Seoul 110-799; Department of Biochemistry (H.-A.S., H.H.), School of Life Sciences, Research Center for Bioresource and Health, Chungbuk National University, Cheongju 361-763; Laboratory of Endocrine Cell Biology (K.C.P., M.S.), National Research Laboratory Program, Chungnam National University College of Medicine, Daejeon 301-721; and Department of Internal Medicine (I.-K.L.), Keimyung University School of Medicine, Daegu 700-712, Korea

Address all correspondence and requests for reprints to: Hueng-Sik Choi, Ph.D., Hormone Research Center, Chonnam National University, Gwangju 500-757, Korea. E-mail: hsc{at}chonnam.chonnam.ac.kr.

Small heterodimer partner (SHP; NR0B2) is an atypical orphan nuclear receptor and acts as a coregulator of various nuclear receptors. Herein, we examined a novel cross talk between SHP and a forkhead transcription factor HNF3 (hepatocyte nuclear factor 3/Foxa. Transient transfection assay demonstrated that SHP inhibited the transcriptional activity of all three isoforms of HNF3, HNF3, ß, and . In vivo and in vitro protein interaction studies showed that SHP physically interacted with HNF3. Adenovirus-mediated overexpression of SHP significantly decreased the mRNA levels of glucose-6-phosphase (G6Pase), cholesterol 7--hydroxylase (CYP7A1), and phosphoenolpyruvate carboxykinase (PEPCK) in HepG2 cells and rat primary hepatocytes. Moreover, the mRNA level of G6Pase was notably increased by down-regulation of SHP with small interfering RNA. Interestingly, HNF3 transactivity was still repressed by SHP128–139 that fails to repress nuclear receptors. Mapping of interaction domain revealed that SHP interacted with forkhead DNA binding domain of HNF3. Gel mobility shift and chromatin immunoprecipitation assays demonstrated that SHP inhibits DNA binding of HNF3. These results suggest that SHP is involved in the regulation of G6Pase, CYP7A1, and PEPCK gene expression via novel mechanism of inhibition of HNF3 activity and expand the role of SHP as a coregulator of other family of transcription factors in addition to nuclear receptors.

NURSA Molecule Pages Link:

Nuclear Receptors:   SHP

This article has been cited by other articles:

				P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation Physiol Rev, January 1, 2009; 89(1): 147 - 191. [Abstract] [Full Text] [PDF]

				H. Miura, Y. Tomaru, M. Nakanishi, S. Kondo, Y. Hayashizaki, and M. Suzuki Identification of DNA regions and a set of transcriptional regulatory factors involved in transcriptional regulation of several human liver-enriched transcription factor genes Nucleic Acids Res., December 15, 2008; (2008) gkn978v1. [Abstract] [Full Text] [PDF]

				M. Takahashi, M. Shibutani, G.-H. Woo, K. Inoue, H. Fujimoto, K. Igarashi, J. Kanno, M. Hirose, and A. Nishikawa Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model Carcinogenesis, November 1, 2008; 29(11): 2218 - 2226. [Abstract] [Full Text] [PDF]

				E. D. Wederell, M. Bilenky, R. Cullum, N. Thiessen, M. Dagpinar, A. Delaney, R. Varhol, Y. Zhao, T. Zeng, B. Bernier, et al. Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing Nucleic Acids Res., August 1, 2008; 36(14): 4549 - 4564. [Abstract] [Full Text] [PDF]

				H.-Y. Seo, Y. D. Kim, K.-M. Lee, A.-K. Min, M.-K. Kim, H.-S. Kim, K.-C. Won, J.-Y. Park, K.-U. Lee, H.-S. Choi, et al. Endoplasmic Reticulum Stress-Induced Activation of Activating Transcription Factor 6 Decreases Insulin Gene Expression via Up-Regulation of Orphan Nuclear Receptor Small Heterodimer Partner Endocrinology, August 1, 2008; 149(8): 3832 - 3841. [Abstract] [Full Text] [PDF]

				D. Chanda, S.-J. Kim, I.-K. Lee, M. Shong, and H.-S. Choi Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E368 - E379. [Abstract] [Full Text] [PDF]

				Y. D. Kim, K.-G. Park, Y.-S. Lee, Y.-Y. Park, D.-K. Kim, B. Nedumaran, W. G. Jang, W.-J. Cho, J. Ha, I.-K. Lee, et al. Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHP Diabetes, February 1, 2008; 57(2): 306 - 314. [Abstract] [Full Text] [PDF]

				K.-G. Park, K.-M. Lee, H.-Y. Seo, J.-H. Suh, H.-S. Kim, L. Wang, K.-C. Won, H.-W. Lee, J.-Y. Park, K.-U. Lee, et al. Glucotoxicity in the INS-1 Rat Insulinoma Cell Line Is Mediated by the Orphan Nuclear Receptor Small Heterodimer Partner Diabetes, February 1, 2007; 56(2): 431 - 437. [Abstract] [Full Text] [PDF]

				J. H. Suh, J. Huang, Y.-Y. Park, H.-A Seong, D. Kim, M. Shong, H. Ha, I.-K. Lee, K. Lee, L. Wang, et al. Orphan Nuclear Receptor Small Heterodimer Partner Inhibits Transforming Growth Factor-beta Signaling by Repressing SMAD3 Transactivation J. Biol. Chem., December 22, 2006; 281(51): 39169 - 39178. [Abstract] [Full Text] [PDF]

				L. Wang, J. Huang, P. Saha, R. N. Kulkarni, M. Hu, Y. Kim, K. Park, L. Chan, A. S. Rajan, I. Lee, et al. Orphan Receptor Small Heterodimer Partner Is an Important Mediator of Glucose Homeostasis Mol. Endocrinol., November 1, 2006; 20(11): 2671 - 2681. [Abstract] [Full Text] [PDF]

				J. Miao, S. Fang, Y. Bae, and J. K. Kemper Functional Inhibitory Cross-talk between Constitutive Androstane Receptor and Hepatic Nuclear Factor-4 in Hepatic Lipid/Glucose Metabolism Is Mediated by Competition for Binding to the DR1 Motif and to the Common Coactivators, GRIP-1 and PGC-1{alpha} J. Biol. Chem., May 26, 2006; 281(21): 14537 - 14546. [Abstract] [Full Text] [PDF]

				J. J. Eloranta, D. Jung, and G. A. Kullak-Ublick The Human Na+-Taurocholate Cotransporting Polypeptide Gene Is Activated by Glucocorticoid Receptor and Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator-1{alpha}, and Suppressed by Bile Acids via a Small Heterodimer Partner-Dependent Mechanism Mol. Endocrinol., January 1, 2006; 20(1): 65 - 79. [Abstract] [Full Text] [PDF]

				Y.-Y. Park, S.-W. Ahn, H.-J. Kim, J.-M. Kim, I.-K. Lee, H. Kang, and H.-S. Choi An autoregulatory loop controlling orphan nuclear receptor DAX-1 gene expression by orphan nuclear receptor ERR{gamma} Nucleic Acids Res., November 28, 2005; 33(21): 6756 - 6768. [Abstract] [Full Text] [PDF]

				B. Cariou, D. Duran-Sandoval, F. Kuipers, and B. Staels Farnesoid X Receptor: A New Player in Glucose Metabolism? Endocrinology, March 1, 2005; 146(3): 981 - 983. [Full Text] [PDF]